Neurological
|
February 5, 2025

The Impact of Mad Cow Disease on Human Health Explained

Written By
Dr. Kristin Robinson ND
Medically Reviewed by
Updated On
February 21, 2025

Mad Cow Disease, also known as Bovine Spongiform Encephalopathy (BSE), caused widespread attention in the 1980s and 1990s as cases were reported in at least 24 countries. 

It was discovered that this disease, which affects cattle, could be passed on to humans in rare cases through infected beef. While the risk of transmission is much lower today, understanding the potential impact of BSE on human health remains important for public awareness and safety.

This article discusses how BSE may impact human health, including its symptoms, diagnosis, treatment options, and the preventive measures implemented since the outbreak.

[signup]

What is Mad Cow Disease?

Bovine Spongiform Encephalopathy (BSE), or Mad Cow Disease, is a neurological disorder that affects cattle. "Bovine" indicates that the disease is specific to cows, while "spongiform" refers to the spongy appearance of brain tissue in affected cows when viewed under a microscope. The term "encephalopathy" signifies that it is a disease of the brain. 

BSE is caused by prions, which are infectious proteins that damage brain tissue. Unlike bacteria or viruses, prions don’t contain genetic material. Instead, they cause healthy proteins to misfold, leading to brain damage. As prions build up in the brain, they create sponge-like holes in the tissue, impairing brain function.

BSE can spread among cattle through contaminated feed, mainly from animal by-products. Infected cows may not show symptoms immediately, but can experience difficulty walking or standing as the disease progresses. Eventually, the damage to their brain becomes severe and leads to death.

Transmission to Humans

While BSE affects cattle, there is concern about the risk of prions being passed to humans through infected beef. If humans consume contaminated beef, they may develop a rare condition called variant Creutzfeldt-Jakob Disease (vCJD), which can cause progressive neurological damage. 

The incubation period for vCJD can be long, sometimes taking years or decades for symptoms to present. During this time, prions may spread in the body, and symptoms may not show until significant brain damage has occurred. 

The mechanisms through which prions affect humans are still being studied.

How Mad Cow Disease Affects Humans

​​Mad Cow Disease, through its human form as vCJD, can severely affect the brain and nervous system.

Symptoms of vCJD

In the early stages, vCJD often presents with subtle symptoms such as depression, anxiety, and memory loss. These early signs can be easily overlooked, which may delay diagnosis. As the disease progresses, more severe neurological symptoms present, including cognitive decline, dementia, and motor impairments, such as difficulty moving or coordinating.

In the later stages, the rapid deterioration of cognitive and motor functions can lead to substantial changes in the individual’s quality of life. While the progression varies, most individuals with vCJD experience rapid decline once the disease advances to this stage.

Impact on the Brain and Body


vCJD is caused by prions that damage brain tissue. Brain scans can show significant brain shrinkage and the development of vacuoles (small holes) in the brain. This progressive damage to the brain is one of the hallmarks of vCJD.

Unfortunately, this damage is irreversible, and as the brain loses its ability to perform essential functions, individuals experience further impairment in movement, thought, and communication.

Case Studies

Case studies of vCJD patients highlight both the medical and emotional challenges of the disease. Families often witness rapid cognitive and motor decline. At the same time, healthcare providers face the difficulty of managing a disease with no known treatment to stop its progression.

One case involved a 48-year-old woman who experienced depression, loss of sleep and appetite, and difficulty speaking. As her condition worsened, symptoms like slowed movement and muscle stiffness appeared. Brain scans and spinal fluid tests confirmed vCJD. This case illustrates the importance of considering vCJD when symptoms like memory concerns, muscle spasms, and balance issues are present.

In another case, a 66-year-old woman with 5 months of rapidly progressing dementia was diagnosed with possible vCJD. Her symptoms included blurry vision, rigidity, and abnormal MRI findings. Despite extensive testing, her condition worsened, and she passed away 7 months later. vCJD was confirmed postmortem. This underlines the challenges of diagnosing vCJD as its symptoms often mimic other conditions like Alzheimer's disease and various dementias.

Diagnosis and Treatment

Diagnosing and managing Mad Cow Disease in humans (vCJD) relies on a combination of diagnostic methods, though treatment options remain limited. Early detection and symptom management are key aspects of care.

Diagnostic Methods

Diagnosing vCJD involves neurological exams and imaging techniques. Brain imaging through MRI can show brain shrinkage or changes in brain tissue, although not until later stages. EEG testing, which measures electrical activity in the brain, may suggest abnormal patterns commonly associated with neurodegenerative diseases like vCJD.

In some cases, blood tests and cerebrospinal fluid (CSF) analysis can help with diagnosis. Specific markers in the CSF (protein 14-3-3) may indicate prion disease. However, no single test can definitively diagnose vCJD until the disease progresses.

Treatment Options

Currently, there is no known cure for vCJD, and treatment is focused on managing symptoms. Palliative care can help enhance the quality of life by addressing pain, discomfort, and mobility challenges. Healthcare providers also manage secondary conditions, such as infections, that may occur from weakened immune function.

Some studies are investigating prion inhibitors and other medications that could slow the spread of prions in the brain. However, these treatments are still in the early stages of development, and further research is required to evaluate their effectiveness.

One such treatment being studied is pentosan polysulfate (PPS), which impacts the function of specific proteins in the body. PPS has been explored for its potential to slow the progression of prion diseases like vCJD. In one case, a 22-year-old man diagnosed with vCJD was treated with PPS for 31 months. While the treatment appeared safe and well-tolerated, it did not stop the disease’s progression. However, the patient lived longer than typically expected (51 months), even though the disease continued to advance.

Emerging research also includes PRN100, a monoclonal antibody developed by the MRC Prion Unit in London.  A small case study involving six patients found the treatment safe and that it reached the brain. In three patients, disease progression seemed to stabilize when the drug was administered at target levels. 

However, due to the small number of patients, more research is needed to draw definitive conclusions. Sadly, all patients passed away as a result of their condition. While still in its early stages, PRN100 represents a promising step in developing targeted treatments for prion diseases. It may lead to new therapies for other neurodegenerative conditions.

Preventive Measures and Food Safety

Preventive measures, which focus on beef safety and regulations in agriculture and meat processing, play an important role in minimizing the risk of mad cow disease (BSE).

Regulations in Agriculture and Meat Processing

The FDA has established safety measures to detect BSE in cattle. Cattle showing signs of illness are tested for prion proteins, and high-risk parts, such as the brain and spinal cord, are prohibited from entering the food supply. These regulations help prevent BSE transmission through beef products.

Meat processing is closely monitored to ensure safety standards are met, including rules for handling, processing, and testing beef. Beef safety programs, including traceability systems, help ensure that contaminated meat does not reach consumers.

How to Protect Yourself

As a consumer, choose beef from trusted sources that follow safety regulations. Look for products with traceability or organic labels, which often reflect higher standards for animal care. While the risk of BSE is low, being informed about where your beef comes from can help you make safer choices.

Broader Implications of Mad Cow Disease

Mad Cow Disease (BSE) has wide-reaching effects beyond human health. It impacts agriculture, the economy, public health, and research efforts. Understanding these implications is key to addressing BSE's global consequences.

Economic Impact

BSE and its link to vCJD have caused significant losses in agriculture and the food industry, due to cattle restrictions and beef export bans. Maintaining safety standards and conducting regular cattle testing places an additional financial burden on farmers, ranchers, and meat processors globally. While vCJD cases remain rare, they still contribute to long-term economic challenges, with healthcare costs rising due to the need for ongoing care.

Public Health and Research Advancements

Research on prion diseases is progressing, helping healthcare providers improve education and early detection.

Studies suggest that reducing prion protein levels in neurons could be a possible strategy for managing prion diseases. Researchers developed a tool called CHARM, which uses zinc finger proteins to target and turn off the gene that produces prion proteins. This method reduces prion protein levels by activating a naturally occurring enzyme to modify DNA. This approach shows potential for further exploration in prion disease research.

While there are no curative treatments yet, experimental approaches like immunotherapy, gene therapy, small-molecule drugs, and stem cell therapy are being explored. However, these treatments still face challenges such as toxicity and low efficacy.

Although vCJD affects about 1 in 1 million people globally each year, its rarity does not lessen its importance as a public health concern. Public health efforts continue to focus on prevention and improving food safety practices to minimize community risk.

[signup]

Key Takeaways

  • Prion diseases, including BSE and vCJD, are rare, progressive, and fatal conditions that affect both humans and animals. Symptoms include cognitive decline, motor dysfunction, and neurological damage. While there is no cure, prevention and early detection remain important.
  • Public health efforts focus on enhancing food safety, minimizing risks through regulations, and supporting ongoing research.
  • Stay informed, share knowledge about prion-related illnesses, and support initiatives that advance food safety and research in this area. 
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. (2024a, February 12). Alzheimer’s Was Rare In Ancient History. Why Is The Risk So High Now? Rupa Health. https://www.rupahealth.com/post/alzheimers-was-rare-in-ancient-history-why-is-the-risk-so-high-now

Achuff, J. (2024b, April 2). From diet to brain: How ketogenic diet and BHB improve memory and synaptic plasticity in alzheimer’s. Rupa Health. https://www.rupahealth.com/post/from-diet-to-brain-how-ketogenic-diet-and-bhb-improve-memory-and-synaptic-plasticity-in-alzheimers

Blake, K. (2023, November 14). Integrative Strategies for Neurodegenerative Disease Management. Rupa Health. https://www.rupahealth.com/post/integrative-strategies-for-neurodegenerative-disease-management

Blevins, H. (2024, May 28). The Blood-Brain Barrier and its Role in Neurodegenerative Diseases. Rupa Health. https://www.rupahealth.com/post/the-blood-brain-barrier-and-its-role-in-neurodegenerative-diseases

Bryant, A. (2024a, October 23). New-Onset Anxiety in Older Adults: A Risk Factor for Parkinson’s Disease. Rupa Health. https://www.rupahealth.com/post/new-onset-anxiety-in-older-adults-a-risk-factor-for-parkinsons-disease

Bryant, A. (2024b, October 25). Most Commonly Ordered Lab Tests By Neurologists. Rupa Health. https://www.rupahealth.com/post/most-commonly-ordered-lab-tests-by-neurologists

BSE Surveillance Information Center. (2024, December 11). Usda.gov. https://www.usda.gov/farming-and-ranching/animal-science/bse-surveillance-information-center

Cassandra , T. (2020). Protein Misfolding - an overview | ScienceDirect Topics. Www.sciencedirect.com. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/protein-misfolding

CDC. (2024a, April 22). About Prion Diseases. Prion Diseases. https://www.cdc.gov/prions/about/index.html#cdc_disease_basics_overview-overview

CDC. (2024b, May 10). Bovine Spongiform Encephalopathy (BSE). Bovine Spongiform Encephalopathy (BSE). https://www.cdc.gov/mad-cow/php/animal-health/index.html

CDC. (2024c, May 10). Bovine Spongiform Encephalopathy (BSE). Bovine Spongiform Encephalopathy (BSE). https://www.cdc.gov/mad-cow/php/animal-health/index.html#cdc_generic_section_2-outbreaks

CDC. (2024d, May 10). Bovine Spongiform Encephalopathy (BSE). Bovine Spongiform Encephalopathy (BSE). https://www.cdc.gov/mad-cow/php/animal-health/index.html#cdc_generic_section_5-risk-to-people

CDC. (2024e, May 13). About Variant Creutzfeldt-Jakob Disease (vCJD). Variant Creutzfeldt-Jakob Disease (VCJD). https://www.cdc.gov/variant-creutzfeldt-jakob/about/index.html

CDC. (2024f, November 12). About Variant Creutzfeldt-Jakob Disease (vCJD). Variant Creutzfeldt-Jakob Disease (VCJD). https://www.cdc.gov/variant-creutzfeldt-jakob/about/index.html#cdc_disease_basics_symptoms-signs-and-symptoms

CDC. (2024g, November 12). About Variant Creutzfeldt-Jakob Disease (vCJD). Variant Creutzfeldt-Jakob Disease (VCJD). https://www.cdc.gov/variant-creutzfeldt-jakob/about/index.html#cdc_disease_basics_testing_screening-diagnosis

CDC. (2024h, November 12). About Variant Creutzfeldt-Jakob Disease (vCJD). Variant Creutzfeldt-Jakob Disease (VCJD). https://www.cdc.gov/variant-creutzfeldt-jakob/about/index.html#cdc_disease_basics_treatment-treatment

Center for Food Safety | Government Regulation | | Government Regulation. (2025). Center for Food Safety. https://www.centerforfoodsafety.org/issues/1040/mad-cow-disease/government-regulation-273

Clinic, C. (2022, January 10). Monoclonal antibodies are proteins made in a lab that bind to one antigen only. They help you fight off germs. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/22246-monoclonal-antibodies#overview

Cloyd, J. (2024, February 27). Exploring Neurotransmitter Testing: A Functional Medicine Perspective on Mental Health. Rupa Health. https://www.rupahealth.com/post/exploring-neurotransmitter-testing-a-functional-medicine-perspective-on-mental-health

Conter, M. (2024). Recent advancements in meat traceability, authenticity verification, and voluntary certification systems. Italian Journal of Food Safety. https://doi.org/10.4081/ijfs.2024.12971

Creedon, K. (2022, April 22). 9 Common Causes Of Dementia. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-dementia

Diorio, B. (2023, January 27). Functional medicine labs that are important for longevity and cognition. Rupa Health. https://www.rupahealth.com/post/functional-medicine-labs-that-are-important-to-longevity-and-cognition

Doctrow, B. (2024, July 22). Developing treatments for prion diseases. National Institutes of Health (NIH). https://www.nih.gov/news-events/nih-research-matters/developing-treatments-prion-diseases

Foglesong Stabile , J. (2024, November 26). How to Incorporate Functional Medicine Into Hospice Patient Care. Rupa Health. https://www.rupahealth.com/post/how-to-incorporate-functional-medicine-into-hospice-patient-care

Foutz, A., Appleby, B. S., Hamlin, C., Liu, X., Yang, S., Cohen, Y., Chen, W., Blevins, J., Fausett, C., Wang, H., Gambetti, P., Zhang, S., Hughson, A., Tatsuoka, C., Schonberger, L. B., Cohen, M. L., Caughey, B., & Safar, J. G. (2017). Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Annals of Neurology, 81(1), 79–92. https://doi.org/10.1002/ana.24833

Friedmann, J. (2025, January 24). White Matter Disease: An Overview of Its Potential Effects. Rupa Health. https://www.rupahealth.com/post/white-matter-disease-an-overview-of-its-potential-effects

Johns Hopkins Medicine. (2021). Neurological Exam. Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/conditions-and-diseases/neurological-exam

Kappes, A. J., Tozooneyi, T., Shakil, G. S., Railey, A. F., McIntyre, K. M., Mayberry, D., Rushton, J., Pendell, D. L., & Marsh, T. L. (2023). Livestock Health and Disease economics: a Scoping Review of Selected Literature. Frontiers in Veterinary Science, 10. https://doi.org/10.3389/fvets.2023.1168649

Khakham, C. (2023, April 20). What is Functional Neurology? Rupa Health. https://www.rupahealth.com/post/functional-medicine-approach-to-neurology

Kojima, G., Tatsuno, B. K., Inaba, M., Velligas, S., Masaki, K., & Liow, K. K. (2013). Creutzfeldt-Jakob Disease: A Case Report and Differential Diagnoses. Hawai’i Journal of Medicine & Public Health, 72(4), 136. https://pmc.ncbi.nlm.nih.gov/articles/PMC3689509/

Labeling Organic Products | Agricultural Marketing Service. (2024). Www.ams.usda.gov. https://www.ams.usda.gov/rules-regulations/organic/labeling#what%20requirements

Liu, F., Wenqi Lü, & Liu, L. (2024). New implications for prion diseases therapy and prophylaxis. Frontiers in Molecular Neuroscience, 17. https://doi.org/10.3389/fnmol.2024.1324702

Mad Cow Disease Factsheet - American College of Veterinary Pathologists. (2012). Www.acvp.org. https://www.acvp.org/page/Mad_Cow_Disease

Maholy, N. (2023, June 21). Evidence based benefits of physical activity for neurological health. Rupa Health. https://www.rupahealth.com/post/evidence-based-benefits-of-exercise-and-physical-activity-for-neurological-health

Mayo Clinic. (2023a). Creutzfeldt-Jakob disease - Diagnosis and treatment - Mayo Clinic. Mayoclinic.org. https://www.mayoclinic.org/diseases-conditions/creutzfeldt-jakob-disease/diagnosis-treatment/drc-20371230

Mayo Clinic. (2023b). Creutzfeldt-Jakob disease: Rare cause of dementia-Creutzfeldt-Jakob disease - Symptoms & causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/creutzfeldt-jakob-disease/symptoms-causes/syc-20371226#symptoms

Mayo Clinic. (2023c). Creutzfeldt-Jakob disease: Rare cause of dementia-Creutzfeldt-Jakob disease - Symptoms & causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/creutzfeldt-jakob-disease/symptoms-causes/syc-20371226#causes

Mayo Clinic. (2023d). Creutzfeldt-Jakob disease: Rare cause of dementia-Creutzfeldt-Jakob disease - Symptoms & causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/creutzfeldt-jakob-disease/symptoms-causes/syc-20371226#complications

Mayo Clinic. (2023e). Creutzfeldt-Jakob disease: Rare cause of dementia-Creutzfeldt-Jakob disease - Symptoms & causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/creutzfeldt-jakob-disease/symptoms-causes/syc-20371226#prevention

Mead, S., Khalili-Shirazi, A., Potter, C., Mok, T., Nihat, A., Hyare, H., Canning, S., Schmidt, C., Campbell, T., Darwent, L., Muirhead, N., Ebsworth, N., Hextall, P., Wakeling, M., Linehan, J., Libri, V., Williams, B., Jaunmuktane, Z., Brandner, S., & Rudge, P. (2022). Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme. The Lancet Neurology, 21(4), 342–354. https://doi.org/10.1016/s1474-4422(22)00082-5

MedlinePlus. (2020). EEG: MedlinePlus Medical Encyclopedia. Medlineplus.gov. https://medlineplus.gov/ency/article/003931.htm

MedlinePlus. (2024). Pentosan Polysulfate: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a602007.html

Parry, A., Baker, I., Stacey, R., & Wimalaratna, S. (2007). Long term survival in a patient with variant Creutzfeldt–Jakob disease treated with intraventricular pentosan polysulphate. Journal of Neurology, Neurosurgery, and Psychiatry, 78(7), 733–734. https://doi.org/10.1136/jnnp.2006.104505

Rasheed, U., Khan, S., Khalid, M., Noor, A., & Zafar, S. (2024). A systemic analysis of Creutzfeldt Jakob disease cases in Asia. Prion, 18(1), 11–27. https://doi.org/10.1080/19336896.2024.2311950

Rumley, E. R., & Wilkerson, J. (2025). Meat Processing Laws in the United States: A State Compilation - National Agricultural Law Center. Nationalaglawcenter.org. https://nationalaglawcenter.org/state-compilations/meatprocessing/

Salehian, R., Sina, F., & Moudi, S. (2021). Creutzfeldt-Jakob disease: A case report. Caspian Journal of Internal Medicine, 12(Suppl 2), S359–S362. https://doi.org/10.22088/cjim.12.0.359

Shim, K. H., Sharma, N., & An, S. S. A. (2022). Prion therapeutics: Lessons from the past. Prion, 16(1), 265–294. https://doi.org/10.1080/19336896.2022.2153551

Sigurdson, C. J., Bartz, J. C., & Glatzel, M. (2019). Cellular and Molecular Mechanisms of Prion Disease. Annual Review of Pathology: Mechanisms of Disease, 14(1), 497–516. https://doi.org/10.1146/annurev-pathmechdis-012418-013109

Sweetnich, J. (2023, May 26). Integrative Treatment Options for Neurological Diagnosis: Specialty Testing, Nutrition, Supplements. Rupa Health. https://www.rupahealth.com/post/4-neurological-conditions-commonly-treated-with-integrative-medicine

Teruya, K., & Doh-ura, K. (2017). Insights from Therapeutic Studies for PrP Prion Disease. Cold Spring Harbor Perspectives in Medicine, 7(3). https://doi.org/10.1101/cshperspect.a024430

Watson, N., Brandel, J.-P., Green, A., Hermann, P., Ladogana, A., Lindsay, T., Mackenzie, J., Pocchiari, M., Smith, C., Zerr, I., & Pal, S. (2021). The importance of ongoing international surveillance for Creutzfeldt–Jakob disease. Nature Reviews Neurology, 17(6). https://doi.org/10.1038/s41582-021-00488-7

Wilson, E. (2025, January 20). Topa Lean Meats Recipes for Healthy and Flavorful Meals. Rupa Health. https://www.rupahealth.com/post/top-lean-meats-recipes-for-healthy-and-flavorful-meals

Yoshimura, H. (2023a, April 18). Preventative Treatment Options for Recurrent Geriatric Infections with Integrative Medicine. Rupa Health. https://www.rupahealth.com/post/preventative-treatment-for-recurrent-geriatric-infections-with-integrative-medicine

Yoshimura, H. (2023b, November 6). Neuroplasticity and Nutrition: The Role of Diet in Brain Resilience and Repair. Rupa Health. https://www.rupahealth.com/post/neuroplasticity-and-nutrition-the-role-of-diet-in-brain-resilience-and-repair

Yoshimura, H. (2023c, December 27). Staying Active in Winter: Functional Medicine Tips for Maintaining Physical Health. Rupa Health. https://www.rupahealth.com/post/staying-active-in-winter-functional-medicine-tips-for-maintaining-physical-health

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Neurological
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.